A new study conducted at the Institute of Cancer Research (ICR) in London indicates that 2 genes may help predict breast cancer survival and guide treatment. According to lead ICR researcher Paul Huang, study results from almost 2,000 HER-2 positive breast cancer patients found that patients "whose tumors had high activity in a gene called F12, but low activity in a gene called STC2, were three times more likely to die within 10 years."
To read more about this study, click here.
No comments:
Post a Comment